rapid test for bloodstream infections (PhenoTest BC Kit)

From Aaushi
Jump to navigation Jump to search

Indications

Clinical significance

Procedure

  • uses proprietary instrument (Pheno System) for analysis

Mechanism of action

  • identifies genetic material in blood homologous to DNA known to be unique to specific bacteria or yeast

Complications

  • false positives
  • correct identification of pathogen in >95% of cases

More general terms

References

  1. FDA News Release. February 23, 2017 FDA allows marketing of test to identify organisms that cause bloodstream infections and provide antibiotic sensitivity results. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm543150.htm